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Abstract 
Introduction:  Hemorrhagic shock is a major cause of morbidity and mortality in trauma 
patients.  Microvascular inflammation occurs during resuscitation following hemorrhagic shock, 
and is a major cause of multiple organ dysfunction and late mortality.  Hypothermia has 
traditionally been associated with poor outcomes in trauma patients, but pre-clinical evidence 
suggests that hypothermia may have some benefit in selected patients.  Our objective was to 
evaluate the effect of induced hypothermia on microvascular inflammation during resuscitation 
from hemorrhagic shock. 
 
Methods:  Intravital microscopy was used to visualize mesenteric venules of 
anesthetized rats in real time to evaluate leukocyte adherence per 100 μm venule length and mast 
cell degranulation.  An optical Doppler velocimeter was used to measure centerline red blood 
cell velocity in order to calculate shear rate.  Measurements were obtained at a baseline control 
period in all animals.  Animals then were divided into normotensive or hypotensive groups.  
Animals in the shock group underwent mean arterial blood pressure reduction to 40-45 mmHg 
for 1 hour via blood withdrawal.  During the first two hours of resuscitation, body temperature of 
the hypothermic group was maintained at 32-34°C, while the normothermic group was 
maintained between 36-38°C.  The hypothermic group was then rewarmed for the final two 
hours of resuscitation. 
 
Results:  Leukocyte adherence was significantly lower after 2 hours in hypothermic 
resuscitation (n=5) compared with normothermic resuscitation (n=6): (3.4±0.8 vs 8.3±1.3, 
p=0.011).  Upon rewarming, leukocyte adherence was not significantly different between 
hypothermic and normothermic shock groups: (5.4±1.1 vs 9.5±1.6, p=0.081).  No significant 
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elevation was observed in normotensive normothermic (n=3) or hypothermic animals (n=4).  
Shear rate decreased significantly from the control period after normothermic resuscitation 
(p<0.05), with no other groups having significant changes.  Mast cell degranulation was 
significantly decreased in the hypothermic (1.02±0.04) vs normothermic (1.22±0.07) shock 
groups (p=0.038) after the experiment compared to the control measures; no significant 
degranulation occurred in normotensive animals. 
 
Conclusions:  Hypothermia during resuscitation attenuates microvascular inflammation 
in rat mesentery following hemorrhagic shock.  Further study is needed to determine the 
underlying mechanisms of hypothermia in reducing microvascular inflammation during 
resuscitation, defining optimal degree of hypothermia, and the timing of this innovative therapy.  
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Introduction 
Background 
Trauma continues to be a major cause of morbidity and mortality in the general 
population.
1
  Along with traumatic brain injury, hemorrhagic shock shares a large responsibility 
for these poor outcomes.
2
  Even with optimal resuscitation, delayed morbidity and mortality 
occurs in this population secondary to microvascular inflammation.  Although major efforts have 
been made in both the laboratory and clinical research environment to overcome this 
inflammatory response to injury and resuscitation, little improvement in standardized care has 
been realized.
3
   
Currently, victims of severe hemorrhagic shock from traumatic injury are treated with 
volume resuscitation.  Blood products are the preferred resuscitation fluids for this patient 
population, but prehospital and continuous in hospital use of blood is costly and potentially 
dangerous.  Isotonic resuscitation fluids, such as normal saline and lactated ringers, are also used 
frequently in this population.  If shock is refractory to these measures after surgical control of 
bleeding, vasoactive medications may be given as a last resort to maintain blood pressure.  There 
has been little change in this treatment paradigm over the last several decades, meaning 
continued poor outcomes for those suffering from severe hemorrhage. 
If patients are transported quickly to a trauma center and receive optimal resuscitation as 
discussed above, patients may very well survive the injury for the first few hours.  Unfortunately, 
there is still major danger lurking for these patients.  Hemorrhagic shock has been shown to 
induce microvascular inflammatory responses that are not attenuated with volume resuscitation, 
and are even made worse in several cases.
4
  Various mechanisms of this injury have been 
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hypothesized, including ischemia-reperfusion injury and systemic hypoxia.
3,5
  It is likely a 
mixture of both of these, with the addition of signaling through cytokines and sympathetic 
activation that leads to this exaggerated inflammatory response.  This causes severe 
microvascular inflammation, leading to multiple organ failure and delayed mortality after the 
initial injury and resuscitation. 
Numerous studies have looked at the cellular and molecular mechanisms contributing to 
microvascular inflammation.  It is now thought that multiple pathways can lead to induction of 
this response, and the pathways are inherently interrelated (Figure 1).  One proposed mechanism 
involves generation of reactive oxygen species at the cellular level secondary to inhibited 
respiration due to an insult (hemorrhage, hypoxia, or ischemia).  These reactive oxygen species 
initiate cytokine formation through mediators such as TNF-α and IL-1β, and endothelial 
activation occurs.
6
  This increases leukocyte adherence and emigration.  Additionally, mast cells 
located in the perivascular tissue are induced to release granules by activation with Ig-E.
7
  These 
granules contain histamine, additional inflammatory cytokines, and even some anti-inflammatory 
markers that modulate immune function.  This complex pathway leads to localized tissue death 
due to edema and apoptosis, ending with multiple organ dysfunction and death of the patient. 
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Figure 1: Mechanism of Microvascular Inflammation 
 
A long held axiom of trauma care has been temperature regulation of the injured patient, 
essentially the maintenance of normothermia (36-38°C) during resuscitation.
8
  This practice has 
been based off several observational studies in the past that have shown a relationship between 
hypothermia (temperature less than 35°C) and increased mortality.  Hypothermia has even 
become accepted as a member of the “deadly triad” of trauma resuscitation (Figure 2).  However, 
there have been no definitive studies pointing to hypothermia as a causative factor of death in the 
trauma patient.  Additionally, some have suggested that hypothermia on presentation to the 
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trauma bay may be an index for injury severity, and may also be a compensatory mechanism to 
preserve tissue viability in the patient.
9
 
 
Figure 2: "Triad of Death" in Traumatology 
 
Hypothermia has seen a recent increase in usage as a therapeutic modality.
10
  It has been 
used in the conduction of cardiac surgery procedures for over 50 years.  Hypothermia has also 
been shown to have a neuroprotective effect on patients with stroke and traumatic brain injury.  
Additionally, induced hypothermia after cardiac arrest has been shown to decrease mortality and 
increase neurological function.
11,12
  A recent case series has even shown that induced 
hypothermia protocols can be used after traumatic cardiac arrest with positive outcomes.
13
  
Study Objective 
Our objective in this study was to determine the effect of induced hypothermia during 
resuscitation from hemorrhagic shock on microvascular inflammation.  We have developed a 
successful model of microvascular inflammation during hemorrhagic shock in our laboratory by 
Hypothermia 
Metabolic 
Acidosis 
Coagulopathy 
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examining rat mesenteric venules via intravital microscopy.
4
  This study was designed to 
evaluate mild hypothermia (32-34°C) during resuscitation as this poses the least risk of 
coagulopathy, and is easy to achieve and maintain without aggressive cooling techniques in the 
trauma patient.
14
  Additionally, we also wanted to study the effects of rewarming the 
hypothermic patient on microvascular inflammation, as this is the common practice in 
traumatology at this point in time.  We chose to evaluate leukocyte adherence and mast cell 
degranulation, two important indices of microvascular inflammation and dysfunction, during the 
course of our experiments.
5,15,16
 
Methods 
Regulatory Considerations 
The experimental protocol was approved by the Institutional Animal Care and Use 
Committee of the University of Kansas Medical Center.  The University of Kansas Medical 
Center is accredited by the American Association for Accreditation of Laboratory Animal Care; 
all procedures were carried out in accordance with National Institute of Health guidelines. 
Surgical Procedures 
Sprague-Dawley rats weighing between 250 to 350 grams were obtained from Harlan 
Laboratories (Indianapolis, IN).  Animals were allowed full access to food and water prior to the 
experiment.  Rats were anesthetized with sodium pentobarbital (40-60 mg/kg IM injection, 
additional doses as needed).  Jugular venous cannulation was performed for administration of 
fluids and blood with a Polyethylene (PE) cannula (PE-50, 0.58mm ID).  Carotid artery 
cannulation was likewise carried out with a PE-50 cannula for withdrawal of blood and 
monitoring of mean arterial pressure (MAP) with a continuous blood pressure analyzer 
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(Micromed, Louisville, KY).  A tracheostomy was performed with PE-240 tubing for definitive 
airway management throughout the experiment.  Midline laparotomy incision was conducted 
with radiocautery (Harvard Apparatus, Holliston, MA). 
Intravital Microscopy 
The animal was placed in the left lateral decubitus position on a Plexiglas stage mounted 
to a Zeiss Axiovert inverted microscope.  A loop of mesentery was draped over a glass cover slip 
in the center of the stage to view a mesenteric venule.  Saline warmed to 37°C was superfused 
over the mesentery to prevent drying, and a square of Saran wrap was also placed over the 
exposed mesentery to assist in this regard.  Mesenteric venules were selected for study based on 
the following 3 criteria: 1) straight, unbranched vessels at least 100 µm in length; 2) no adjacent 
vessels within 100 µm of the venule; 3) vessel diameter of 20-40 µm.  Images of the mesentery 
(40x objective, 10x eyepiece) were recorded using Mini-DV videocassette recorder (Sony, 
Tokyo, Japan) using a video camera and time-date generator (Panasonic, Kadoma City, Japan).   
Venular diameter was obtained using a video caliper (Microcirculation Research 
Institute, Texas A&M University, College Station, TX).  An optical Doppler velocimeter 
(Microcirculation Research Institute, Texas A&M University, College Station, TX) was used to 
measure red blood cell (RBC) centerline velocity in mesenteric venules.  Average RBC velocity 
was calculated by dividing centerline velocity by 1.6.  Shear rate was then calculated as 8 
multiplied by RBC velocity divided by venular diameter.   
Leukocyte Adherence and Mast Cell Degranulation 
Leukocyte adherence and mast cell degranulation were measured during offline playback 
of recorded videotapes.  Leukocyte adherence was measured over each minute by counting the 
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number of leukocytes that remained stationary for longer than 30 seconds in a 100 µm length of 
venule.  Tapes were analyzed two times by and experienced observer to ensure accurate counting 
of leukocytes.  Mast cell degranulation was identified by superfusing the mesentery with 
ruthenium red, a chemical that stains degranulated mast cells.  Images of mast cells were 
collected during the control period, then once again at the conclusion of the experiment.  These 
images were converted to digital grayscales and phase inverted.  Relative light intensity of each 
mast cell was measured using the ImageJ program (NIH, Bethesda, MD), and the degree of 
degranulation was quantified as a mast cell degranulation index (MDI) equal to the ratio of  the 
end of experiment to control period intensities.  
Experimental Protocol 
The experimental groups (Figure 3) consisted of normothermic normotensive animals 
(n=3), normotensive with hypothermia (n=4), normothermic hemorrhagic shock (n=6), and 
hemorrhagic shock with hypothermia (n=5).  Temperature was recorded with a rectal 
thermometer, and maintained at 36-38°C with a homeothermic blanket and a heat lamp.  Animals 
were allowed to stabilize after surgery for a 30 minute control period prior to beginning the 
experiment.  Hemorrhagic shock was induced by withdrawal of blood from the carotid artery 
into a syringe containing 100 unit of heparin.  A MAP of 40-45 mmHg was maintained for a 
period of one hour.  At the end of this period, the shed blood was returned to the animal via the 
jugular cannula, as well as two times the volume of blood in normal saline.  For those 
undergoing hypothermia, animals were allowed to naturally begin cooling during hemorrhagic 
shock, with a target of 32-34°C at the end of the shock period.  Animals needing additional 
cooling at this point were subjected to air cooling via a fan.  The hypothermia was maintained for 
a two hour time period, after which the animals underwent re-warming to 36-38°C for 2 hours.  
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Leukocyte adherence and physiologic variables were recorded every 15 minutes throughout the 
experiment.  Mast cell degranulation was recorded at the end of the control period and at the end 
of the experiment. 
 
Figure 3: Experimental Design and Group Configuration 
Chemicals 
Ruthenium red was obtained from Sigma (St. Louis, MO). 
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Statistical Analysis 
Data was expressed as mean ± SE for continuous variables.  MAP and rectal temperature 
were analyzed with one-way ANOVA with bonferoni’s post-hoc correction to characterize all 
between group differences at each time point.  Student’s t test was used to make direct 
comparisons in differences of leukocyte adherence between hypothermic shock and 
normothermic shock groups, between normothermic normotensive and hypothermic 
normotensive groups, and between each shock group individually with the normothermic 
normotensive group (acting as a longitudinal baseline comparison) at hourly time points during 
resuscitation.  Shear rate was evaluated in the same manner.  Paired t test was used to compare 
shear rates from the control period to the final resuscitation time point within each group to 
determine change from the control period.  Differences in mast cell degranulation index were 
compared using Student’s t test.  Differences were considered significant when p≤0.05.  
Statistical analysis was carried out using SAS 9.3 (SAS Institute, Cary, NC). 
Results 
Physiological Measures 
Figure 4 displays rectal temperatures recorded throughout the experiment.  Animals in 
the hypothermic shock group gradually cooled during shock, and were maintained at 32-34°C for 
2 hours.  The rewarming took place rapidly over approximately one hour in this group, and was 
maintained at 36-38°C for the remainder of the experiment.  There were no significant 
differences between the like temperature groups.  The hypothermic groups had significantly 
lower temperatures than the normothermic groups from start of resuscitation to 30 minutes into 
the rewarming period (p<0.05).  MAP of the animals is displayed in Figure 5 below.  Shock was 
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maintained for 60 minutes, and resuscitation provided initial pressures near baseline.  This 
pressure gradually decreased as the experiment went on during the 4 hour resuscitation period in 
all 4 groups.  The shock groups had significantly lower MAPs then the normotensive groups 
during the shock period (p<0.05).  Additionally, the hypothermic normotensive group had a 
significantly higher MAP then the other groups from 30 minutes of shock to 30 minutes into the 
rewarming (p<0.05)  period; this was expected due to known increases in MAP with 
hypothermia.   
 
Figure 4: Rectal Temperatures; #:  significant difference between hypothermic groups and 
normothermic groups (p<0.05). 
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Figure 5: Mean Arterial Blood Pressure; #: Significant difference between shock and 
normotensive groups (p<0.05).  *: Significant difference between hypothermic normotensive and 
all other groups (p<0.05). 
Calculated shear rates are shown in Figure 6.  Shear rates in the hypothermic shock group 
did not significantly change over the course of the experiment when compared to control time 
period measurements (p>0.05), while there was a significant decrease within the normothermic 
shock group over the course of the experiment from the control period measure to the end of 4 
hours of resuscitation (p<0.05).  There were no significant changes in shear rates within the two 
normotensive groups. 
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Figure 6: Wall Shear Rate; There were no significant differences between groups.  However, 
there was a significant decrease within the normothermic shock group between the control period 
and the end of resuscitation at 4 hours. 
Leukocyte Adherence 
Figures 7-10 shows photographs of rat mesenteric venules in the normothermic sham, 
hypothermic sham, normothermic shock, and hypothermic shock groups at control, 2 hours into 
resuscitation, and 4 hours into resuscitation.   
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Figure 7: Normothermic Normotensive Mesenteric Venule; From top to bottom: Control, 2 
hours post resuscitation, and 4 hours post resuscitation.  Blue arrows indicate adherent 
leukocytes.  Black dots are part of the optical Doppler velocimeter and white bars outline 100 
µm length segment. 
14 
 
 
Figure 8: Hypothermic Normotensive Mesenteric Venule; From top to bottom: Control, 2 
hours post resuscitation, and 4 hours post resuscitation.  Blue arrows indicate adherent 
leukocytes.  Black dots are part of the optical Doppler velocimeter and white bars outline 100 
µm length segment. 
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Figure 9: Normothermic Hemorrhagic Shock Mesenteric Venule; From top to bottom: 
Control, 2 hours post resuscitation, and 4 hours post resuscitation.  Blue arrows indicate adherent 
leukocytes.  Black dots are part of the optical Doppler velocimeter and white bars outline 100 
µm length segment. 
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Figure 10: Hypothermic Hemorrhagic Shock Mesenteric Venule; From top to bottom: 
Control, 2 hours post resuscitation, and 4 hours post resuscitation.  Blue arrows indicate adherent 
leukocytes.  Black dots are part of the optical Doppler velocimeter and white bars outline 100 
µm length segment. 
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The number of adherent leukocytes in a 100 µm length of venule is shown for all 4 
experimental groups in Figure 11.  Leukocyte adherence was significantly lower in the 
hypothermic shock group than in the normothermic shock group at the 2 hour time point 
(3.4±0.8 vs 8.3±1.3, p=0.011), but this difference became non-significant at the end of the 
rewarming period (5.4±1.1 vs 9.5±1.6, p=0.081).  The increase in leukocyte adherence in the 
hemorrhagic shock groups as compared to the normothermic normotensive animals  became 
significant at 1 hour after beginning resuscitation in the normothermic shock group, while the 
increase became significant at 3 hours (during rewarming) in the hypothermic shock group (both 
p<0.05).  Normotensive animals did not have significant changes in leukocyte adherence 
between the two groups. 
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Figure 11: Leukocyte Adherence in Mesenteric Venules; #: Significant difference between 
normothermic shock and hypothermic shock group (p=0.011).  *: Significant difference between 
normothermic shock and normothermic normotensive groups (p<0.05).  **: Significant 
difference between both shock groups and the normothermic normotensive group (p<0.05). 
Mast Cell Degranulation 
Figures 12 and 13 show photographs of mast cells for the normothermic shock group and 
the hypothermic shock group (respectively) during the control period and after 4 hours of 
resuscitation.  Mast cell degranulation index was significantly decreased after the 4 hours 
resuscitation period compared to control period measures in the hypothermic shock group 
(1.02±0.04) as compared to the normothermic shock group (1.22±0.07, p=0.038).  No significant 
degranulation occurred in the normothermic or the hypothermic normotensive groups. 
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Figure 12: Mast Cell Degranulation in Normothermic Shock; Left: Control period.  Right: 
After 4 hours of resuscitation.  Pink color represents pickup of ruthenium red dye due to mast 
cell degranulation.  Black dots are part of the optical Doppler velocimeter, and the white lines 
represent a 100 µm length. 
 
Figure 13: Mast Cell Degranulation in Hypothermic Shock; Left: Control period.  Right: 
After 4 hours of resuscitation.  Pink color represents pickup of ruthenium red dye due to mast 
cell degranulation.  Black dots are part of the optical Doppler velocimeter, and the white lines 
represent a 100 µm length. 
Discussion 
We have shown that induced hypothermia during resuscitation from hemorrhagic shock 
significantly attenuates leukocyte adherence and mast cell degranulation in the rat mesenteric 
microcirculation.  The decreased leukocyte adherence between hypothermic and normothermic 
resuscitation was statistically significant after the hypothermic period, but was not statistically 
significant after rewarming occurred.  We also observed a significant decrease in shear rates 
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during the resuscitation period in the normothermic cohort, while there was no significant 
decrease during resuscitation of hypothermic animals. 
Leukocyte adherence has been shown previously to be a mediator of microvascular 
dysfunction during hemorrhagic shock.
4
  The increase in leukocyte adherence has been linked to 
several other indices of inflammation, such as mast cell degranulation, reactive oxygen species 
(ROS) formation, and increased vascular permeability.  It is thought that ROS formation 
secondary to the ischemia-reperfusion injury that occurs during hemorrhagic shock and 
resuscitation is a cause of endothelial dysfunction that leads to increased leukocyte adherence 
and vascular permeability.  Mast cell degranulation occurs in response to oxidative stress as well 
as when inflammatory mediators extravasate through the damaged endothelium.  The 
degranulation of mast cells further increases ROS formation and leukocyte adherence.  This 
cycling cascade continues for several hours post-injury, and is responsible for much of the 
delayed morbidity and mortality in patients suffering from hemorrhagic shock injury. 
There have been several previous laboratory studies examining the effect of hypothermia 
on hemorrhagic shock.
17,18
  Although the results have generally been favorable, there have been 
others that have not shown benefits.  Childs and colleagues showed that pretreating animals with 
mild and moderate hypothermia prior to hemorrhagic shock attenuated ROS formation and 
vascular permeability during the resuscitation period.
19
  These findings support the results we 
have discussed above, and generally fit with the physiology of microvascular inflammation 
discussed above.  It is important to note that their study pretreated with hypothermia and 
maintained constant temperature throughout the experiment, while we used a model that 
involved allowing animals to cool and maintaining the hypothermic range as would be done in 
actual resuscitation settings.  Additionally, it has been shown that moderate hypothermia 
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decreases systemic oxidative stress during intestinal ischemia-reperfusion injury in the rat.
20
  It 
seems clear that reduced ROS has some role in the protective effect of hypothermia during shock 
and resuscitation, but the exact mechanism of this process will require further study. 
Other laboratory studies have directly examined mortality during hemorrhagic shock with 
hypothermia.  Several studies indicate decreased early mortality with mild to moderate 
hypothermia during resuscitation from hemorrhagic shock in rat models.
21-24
  The few studies 
that did look at long term outcomes had mixed results.
22,25,26
  Additionally, large laboratory 
animal models have shown that environmental (natural cooling) hypothermia has similar 
mortality to normothermia.
27
  These studies are routinely conducted with a small number of 
animals, and this could account for some of the variations in outcomes.  It is also important to 
point out that the method of hemorrhagic shock induction is different between studies, and this 
makes aggregating the results difficult.  We chose to use a pressure-controlled hemorrhagic 
shock model in our study due to earlier studies suggesting animals with hypothermia had 
increased MAPs during volume-controlled shock, which is a confounder for looking at the effect 
of hypothermia alone on the microcirculation.
22,24,28
 
The mechanism of protection of the microvasculature with induced hypothermia during 
resuscitation from hemorrhagic shock remains unclear.  A study in rats showed that IL-1β and 
IL-6 were decreased in hypothermic resuscitation, but the study did not have enough power to 
call it a significant difference.
29
  The same study did find that IL-10, an anti-inflammatory 
cytokine, was elevated in hypothermia, but once again the study was underpowered to detect the 
difference.  An interesting finding was that TNF-α was significantly increased after hypothermic 
resuscitation.  This has also been suggested by other studies looking at traumatic brain injury 
with hypothermia for neuroprotection.  Although this response seems counter-intuitive, delayed 
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increased levels of TNF-α may help decrease certain ROS products, and may decrease metabolic 
demand on myocardium and peripheral tissues.  These cytokines also play a role in modulating 
selectins, intracellular adhesion molecules, and mast cells.  This supports our findings of 
decreased leukocyte adherence and mast cell degranulation in the hypothermic resuscitation. 
Findings in the human population regarding hypothermia in the trauma population have 
been largely negative.
8
  Many observational studies have linked hypothermia on arrival to the 
hospital as a negative prognostic indicator.  Additionally, one prospective study showed that 
rapid rewarming of hypothermia using intravascular warming was superior to passive, slower 
rewarming in outcomes.  These findings have led to the creation of a dogma in the trauma field 
that hypothermia is to be avoided at all costs during resuscitation.  However, a recent case series 
reported successful outcomes following induced hypothermia after traumatic cardiac arrest.
13
  
Additionally, numerous studies have shown a neuroprotective effect of hypothermia in patients 
suffering from traumatic brain injury. 
There is also some debate about what hypothermia in a trauma patient actually means: is 
hypothermia a pathological factor leading to increased morbidity and mortality, or is it a 
physiological compensatory mechanism?  While many would argue that it is a pathological 
factor based on clinical data, one needs to consider that most of this data is observational in 
nature, and cannot determine causality.  In laboratory studies, it has been shown that 
hemorrhagic shock lowers the thermoregulatory set point.
30
  It is also known that hypothermia 
decreases metabolic demand and tissue oxygenation requirements, and has a positive effect on 
MAP due to peripheral vasoconstriction.  It would seem from this data that hypothermia is a 
physiological compensatory mechanism.  Further prospective and randomized studies in humans 
may help to determine this once and for all, but there are several barriers to this research: 
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namely, mixed laboratory results and lack of large animal models proving the concept.  These 
should be goals of further research. 
Our study has several strengths.  We used a pressure-controlled hemorrhagic shock 
model in our study in order to limit the increased MAP effect of hypothermia, as to eliminate this 
as a confounder.  We allowed the animal to cool during shock, and simply maintained the 
hypothermia during the first two hours of resuscitation, simulating clinical conditions that 
patients experience.  We also examined 2 hours of rewarming, to see if the effect carried over 
after acute resuscitation. 
There also exist several limitations to our model.  Since our model involves non-survival 
surgical methods, we were not able to assess mortality differences between normothermic and 
hypothermic resuscitation.  It remains unclear what the proper duration of hypothermia during 
the resuscitation period should be; there are various lengths used in the current literature, and we 
selected 2 hours due to our current hemorrhagic shock models looking at 2 hour resuscitation 
period outcomes.  Although we carried out rewarming, it is difficult to tell whether the rise in 
leukocyte adherence during that time period was due to the warming or simply the length of the 
experiment.  We postulate that this increase was due to warming as evidenced by the plateau in 
leukocyte adherence reached near the end of hypothermia, and no increase was observed during 
rewarming of the hypothermic normotensive animals. 
One important question that developed as a result of our methodology was whether 
hypothermia actually prevents microvascular inflammation or delays the onset.  Since we only 
kept the subjects hypothermic for the first 2 hours of resuscitation, we are unable to predict what 
effects longer periods of hypothermia may have in terms of continued microvascular 
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inflammation.  Additionally, we observed increased leukocyte adherence in the rewarming 
period, but we have no way of currently knowing if this was caused by the rewarming, or if this 
was simply a delayed inflammatory response secondary to the hypothermic period.  One 
important factor to note is that the rewarming in our experiments took place rapidly, at 
approximately 2-3 °C per hour.  This is much faster than recommended rewarming times with 
therapeutic induced hypothermia, and may have led to the increase in leukocyte adherence.  
Further studies to investigate this novel finding will be needed to clarify what is happening in 
this instance. 
Conclusions 
We conclude that induced hypothermia (32-34°C) during resuscitation from hemorrhagic 
shock decreases leukocyte adherence and mast cell degranulation in the rat mesenteric 
circulation.  Furthermore, hypothermia did not cause microvascular inflammation in 
normotensive animals.  Probable mechanisms for this observed benefit include decreased ROS, 
altered cytokine signaling, and maintenance of the microvascular endothelial integrity.  Further 
research is warranted to examine the optimal time of hypothermia, the optimal degree of cooling, 
and the effect of rewarming on microvascular inflammation. 
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